NASDAQ:HOLX

Hologic - HOLX Stock Forecast, Price & News

$84.68

+0.24 (+0.28%)

(As of 02/3/2023 12:00 AM ET)

Add

Compare

Today's Range: $83.45
▼
$85.31
50-Day Range: $73.31
▼
$84.68
52-Week Range: $59.78
▼
$85.31

Volume: 1.69 million shs
Average Volume: 1.96 million shs
Market Capitalization: $20.88 billion

P/E Ratio: 21.60
Dividend Yield: N/A
Price Target: $83.54

Institutional Ownership

Hologic MarketRank™ Forecast

Analyst Rating: Hold
2.47 Rating Score
Upside/Downside: 0.7% Downside
$84.08 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: -1.05
Upright™ Environmental Score
News Sentiment: 0.49
Based on 42 Articles This Week
Insider Trading: Selling Shares
$2.05 M Sold Last Quarter
Proj. Earnings Growth: 7.59%
From $3.69 to $3.97 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.39 out of 5 stars

Medical Sector

192nd out of 1,028 stocks

X - Ray Apparatus & Tubes Industry

1st out of 2 stocks

2.2

Analyst's Opinion

Consensus Rating
Hologic has received a consensus rating of Hold. The company's average rating score is 2.47, and is based on 7 buy ratings, 8 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $84.08, Hologic has a forecasted downside of 0.7% from its current price of $84.68.
Amount of Analyst Coverage
Hologic has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

N/A

Short Interest

Short Interest
There is no current short interest data available for HOLX.

0.0

Dividend Strength

Dividend Yield
Hologic does not currently pay a dividend.
Dividend Growth
Hologic does not have a long track record of dividend growth.

4.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Hologic has received a 63.78% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Ultrasound machines", "Medical x-ray machines", "Medical image enhancement software", and "Medical laboratory automation systems" products. See details.
Environmental Sustainability
The Environmental Impact score for Hologic is -1.05.

3.0

News and Social Media Coverage

News Sentiment
Hologic has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 42 news articles for Hologic this week, compared to 6 articles on an average week.
Search Interest
16 people have searched for HOLX on MarketBeat in the last 30 days.
MarketBeat Follows
6 people have added Hologic to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Hologic insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,047,780.00 in company stock.
Percentage Held by Insiders
Only 1.66% of the stock of Hologic is held by insiders.
Percentage Held by Institutions
95.17% of the stock of Hologic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Hologic are expected to grow by 7.59% in the coming year, from $3.69 to $3.97 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Hologic is 21.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 128.60.
Price to Earnings Ratio vs. Sector
The P/E ratio of Hologic is 21.60, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 83.55.
Price to Earnings Growth Ratio
Hologic has a PEG Ratio of 1.51. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Hologic has a P/B Ratio of 4.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Hologic (NASDAQ:HOLX) Stock

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment consists of products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment involves the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.